Hôtel Dieu de France Hospital   Report issue

Academic/Hospital Phase 2 Phase 4
Founded: Beirut Lebanon (1883)

Organization Overview

First Clinical Trial
2017
NCT03351972
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

CH de Narbonne HÔTEL DIEU | CHU Hotel Dieu Nantes | CIC1413, Hôtel Dieu - CHU Nantes | Hotel-Dieu de France | Hôtel Dieu de France Hospital | Hotel Dieu Hospital

Active Ingredients

Drugs in Phase 4 Trials (1)

polyethylene glycol (1 trial)

Drugs in Phase 2 Trials (3)

acetaminophen (tylenol) (1 trial)

bnt162b2 (1 trial)

red rice yeast extract (1 trial)

Drugs in Other Trials (3)

carboplatin (paraplatin) (1 trial)

cisplatin (platinol) (1 trial)

paclitaxel (taxol) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Celiac Disease (Phase 4)

Drug-Related Side Effects and Adverse Reactions (Phase 2)

Dyslipidemias (Phase 2)

Hyperlipidemias (Phase 2)

Hyperlipoproteinemias (Phase 2)

Inflammatory Bowel Diseases (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 7